New system that defines Huntington's disease will 'revolutionize' drug trials
A novel staging framework that assesses the progression of Huntington's disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; this 'significant' ...
Jun 16, 2022
0
11